However, current clinical evidence does not clarify whether NLRP3 inflammasome contributes to the pathophysiology of RA, or whether its activation occurs rather as a consequence of the initiation of synovial inflammatory processes. Here, NLRP3 is linked to rheumatoid arthritis.